Your browser doesn't support javascript.
loading
Pilot drug and therapeutic committee programme in Sierra Leone: A descriptive mixed method study.
Kabba, John Alimamy; Koroma, Mark Momoh; James, Peter Bai; Kitchen, Chenai; Xu, Sen; Chang, Jie; Saeed, Amna; Malik, Usman Rashid; Jiang, Minghuan; Fang, Yu.
Afiliación
  • Kabba JA; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi'an Jiaotong University, Xi'an, China.
  • Koroma MM; Center for Drug Safety and Policy Research, Xi'an Jiaotong University, Xi'an, China.
  • James PB; Shaanxi Center for Health Reform and Development Research, Xi'an, China.
  • Kitchen C; Research Institute for Drug Safety and Monitoring, Institute of Pharmaceutical Science and Technology, China's Western Technological Innovation Harbor, Xi'an, China.
  • Xu S; Department of Epidemiology, School of Public Health, Southern Medical University (Guangdong Provincial Key Laboratory of Tropical Disease Research), Guangzhou, Guangdong, China.
  • Chang J; Faculty of Pharmaceutical Sciences, College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.
  • Saeed A; Australian Research Centre in Complementary and Integrative Medicine, Faculty of Health, University of Technology Sydney, Sydney, NSW, Australia.
  • Malik UR; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi'an Jiaotong University, Xi'an, China.
  • Jiang M; Center for Drug Safety and Policy Research, Xi'an Jiaotong University, Xi'an, China.
  • Fang Y; Shaanxi Center for Health Reform and Development Research, Xi'an, China.
Br J Clin Pharmacol ; 89(1): 20-33, 2023 01.
Article en En | MEDLINE | ID: mdl-33398910
ABSTRACT

AIMS:

Irrational medicine use is a global crisis, but incidences are proportionately higher in low- and middle-income countries such as Sierra Leone. This study explores the structure, functions and challenges of drug and therapeutics committees (DTCs), an intervention towards irrational medicine use recently piloted in Sierra Leone.

METHODS:

A 2-phase mixed-method study design was used in this study. Firstly, a cross-sectional survey was conducted on all pharmacists who have worked for at least 1 year in DTC-piloted hospitals, using an online questionnaire to assess DTCs' structure, indicators and challenges. In phase 2, all eligible pharmacists were invited for a semistructured online interview using the WhatsApp messaging application to get deeper insights into the key issues that emerged from the survey; however, only 5 of the 7 consented to participate. MS Excel 2019 and NVivo version 12 were respectively used for data management and analysis.

RESULTS:

A total of 6 survey responses and 5 interviews were included in the analysis. Participants are pharmacists from the 7 hospitals in Sierra Leone where DTC was piloted. Most DTCs are comprised of a minimum of 10 members consisting of both medical and hospital administrative staff. The main functions of DTCs are ensuring rational medicines use, monitoring and reporting adverse drug reactions. All 7 hospitals with established pilot DTCs have different subcommittees operating at varying functionality levels, ranging from effective to nonfunctional. The main challenges in DTC functions and maintenance are funding (n = 6), DTC decision implementation (n = 4), and unmotivated members (n = 4). Strategies suggested to improve DTCs at public hospitals and nationwide include resource allocation, monitoring and evaluating DTC functions and its members' capacity building.

CONCLUSION:

DTCs present a compelling opportunity towards achieving rational medicines use at the hospital level in Sierra Leone. Nonetheless, the lack of funding and operational resources are significant limitations that must be noted by policymakers before expanding DTC programmes to other hospitals in Sierra Leone.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Farmacéuticos / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos Tipo de estudio: Qualitative_research / Risk_factors_studies Límite: Humans País/Región como asunto: Africa Idioma: En Revista: Br J Clin Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Farmacéuticos / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos Tipo de estudio: Qualitative_research / Risk_factors_studies Límite: Humans País/Región como asunto: Africa Idioma: En Revista: Br J Clin Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: China